Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Journal for ImmunoTherapy of Cancer

Fig. 2

From: Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab

Fig. 2

PD-1+ and PD-L1+ cell densities correlate with clinical response to anti-PD-1. a Responders (R) had significantly higher median densities (±IQR) of PD-1+ when compared to non-responders (NR) b CD8+ cell densities were not significantly different between the two groups. c, d R had higher median densities (±IQR) of PD-L1+ cells as well as PD-L1+ tissue area when compared to NR. *p < 0.05. Assessments were made on the total TME (IT+PT). Results for each individual region are presented in Additional file 1: Figures S2 and Figure S4

Back to article page